Credit Suisse »

Iovance Biotherapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 2.8M 8.13
2023-09-30 $13M 2.8M 4.55
2023-06-30 $20M 2.8M 7.04
2023-03-31 $17M 2.7M 6.11
2022-12-31 $17M 2.7M 6.39
2022-09-30 $25M 2.6M 9.57
2022-06-30 $29M 2.6M 11.05
2022-03-31 $42M 2.5M 16.65
2021-12-31 $47M 2.4M 19.09
2021-09-30 $60M 2.4M 24.65
2021-06-30 $63M 2.4M 26.02
2021-03-31 $76M 2.4M 31.66
2020-12-31 $1.2M 26k 46.40
2020-09-30 $1.8M 56k 32.93
2020-06-30 $2.1M 78k 27.40
2020-03-31 $228k 7.6k 29.85
2019-12-31 $40M 1.4M 27.68
2019-09-30 $25M 1.5M 16.67
2019-06-30 $39M 1.6M 24.53
2019-03-31 $18M 1.9M 9.53
2018-12-31 $17M 1.9M 8.83
2018-09-30 $18M 1.6M 11.21
2018-06-30 $13M 1.0M 12.80
2018-03-31 $25M 1.5M 16.90
2017-12-31 $8.8M 1.1M 8.01
2017-09-30 $571k 74k 7.75
2017-06-30 $195k 27k 7.36